EDGAR Filing Documents for 0001193125-12-032280

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] [amend]

SEC Accession No. 0001193125-12-032280

Filing Date

2012-01-31

Accepted

2012-01-31 17:01:05

Documents

Period of Report

2010-12-31

Filing Date Changed

2012-01-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20F/A	d287955d20fa.htm	20-F/A	52999
2	EXHIBIT 4.2	d287955dex42.htm	EX-4.2	615537
3	EXHIBIT 4.3	d287955dex43.htm	EX-4.3	93568
4	EXHIBIT 4.4	d287955dex44.htm	EX-4.4	476706
5	EXHIBIT 4.5	d287955dex45.htm	EX-4.5	358751
6	EXHIBIT 4.6	d287955dex46.htm	EX-4.6	328386
7	EXHIBIT 4.7	d287955dex47.htm	EX-4.7	284131
8	EXHIBIT 4.8	d287955dex48.htm	EX-4.8	337145
	Complete submission text file	0001193125-12-032280.txt		2548292

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-34949 | Film No.: 12559926
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1